FLEXIBZUMAB Trademark

Trademark Overview


On Thursday, June 24, 2021, a trademark application was filed for FLEXIBZUMAB with the United States Patent and Trademark Office. The USPTO has given the FLEXIBZUMAB trademark a serial number of 90792277. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Thursday, June 20, 2024. This trademark is owned by Elastrin Therapeutics Inc.. The FLEXIBZUMAB trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, a drug delivery system comprising monoclonal antibodies for guiding therapeutic agents to a target tissue; therapeutic pharmaceutical for the treatment of cardiovascular diseases, high blood pressure, arteriosclerosis, aneurysms, diabetes, kidney diseases, and chronic obstructive pulmonary disease (COPD), the forgoing containing monoclonal antibodies; monoclonal antibodies for medical and veterinary purposes; monoclonal antibody preparations for therapeutic purposes; monoclonal antibodies for targeting drugs to calcified tissue for therapeutic purposes
flexibzumab

General Information


Serial Number90792277
Word MarkFLEXIBZUMAB
Filing DateThursday, June 24, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateThursday, June 20, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 26, 2022

Trademark Statements


Goods and ServicesPharmaceutical preparations, namely, a drug delivery system comprising monoclonal antibodies for guiding therapeutic agents to a target tissue; therapeutic pharmaceutical for the treatment of cardiovascular diseases, high blood pressure, arteriosclerosis, aneurysms, diabetes, kidney diseases, and chronic obstructive pulmonary disease (COPD), the forgoing containing monoclonal antibodies; monoclonal antibodies for medical and veterinary purposes; monoclonal antibody preparations for therapeutic purposes; monoclonal antibodies for targeting drugs to calcified tissue for therapeutic purposes

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, March 22, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameElastrin Therapeutics Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSIMPSONVILLE, SC 29681

Party NameElastrin Therapeutics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSIMPSONVILLE, SC 29681

Trademark Events


Event DateEvent Description
Monday, June 28, 2021NEW APPLICATION ENTERED
Wednesday, September 8, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, December 8, 2021TEAS VOLUNTARY AMENDMENT RECEIVED
Monday, December 13, 2021ASSIGNED TO LIE
Monday, December 13, 2021PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Wednesday, March 16, 2022ASSIGNED TO EXAMINER
Tuesday, March 22, 2022EXAMINERS AMENDMENT -WRITTEN
Tuesday, March 22, 2022EXAMINERS AMENDMENT E-MAILED
Tuesday, March 22, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, March 22, 2022EXAMINER'S AMENDMENT ENTERED
Tuesday, March 22, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 6, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 26, 2022PUBLISHED FOR OPPOSITION
Tuesday, April 26, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 21, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 13, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, December 13, 2022SOU EXTENSION 1 FILED
Tuesday, December 13, 2022SOU EXTENSION 1 GRANTED
Thursday, December 15, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 1, 2023ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, June 20, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, June 20, 2023SOU EXTENSION 2 FILED
Tuesday, June 20, 2023SOU EXTENSION 2 GRANTED
Thursday, June 22, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 12, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, December 12, 2023SOU EXTENSION 3 FILED
Tuesday, December 12, 2023SOU EXTENSION 3 GRANTED
Thursday, December 14, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 20, 2024SOU TEAS EXTENSION RECEIVED
Thursday, June 20, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 20, 2024SOU EXTENSION 4 GRANTED
Thursday, June 20, 2024SOU EXTENSION 4 FILED